People
Eramol was created by Eric Che and Peter Mollison.
Eric and Peter embrace challenges with an inspired and forward-thinking approach. Eramol was founded on the shared values of the co-founders to offer a tailored and responsive clinical trial manufacturing services to sponsors with a wide set of requirements.
CEO & Co-Founder
Eric has worked in the pharmaceutical sector for over 15 years, since completing his pharmacist training in the NHS. He is an eligible EU Qualified Person, responsible for supply chain audit oversight and batch release for clinical and commercial products. Eric has worked with a broad range of sterile and non-sterile dosage forms including orphan products as well as time critical sterile and veterinary products. He holds leadership roles in quality, delivering a green field manufacturing facility design project, GMP licence applications and building brand-new quality teams.
CEO & Co-Founder
Peter has over 15 years’ experience in the pharmaceutical industry. Qualifying as a pharmacist in 2004, he worked at the Institute of Cancer Research on pharmacogenomic and drug discovery, before moving into commercial and clinical sterile and non-sterile production roles in the UK NHS and commercial organisations. Since 2009, he has worked in Quality roles covering dosage forms, including radiopharmaceuticals and ATMPs. Gaining QP status in 2014, Peter performed batch release for large and small-scale pharmaceutical EU organisations, before continuing as a consultant, overseeing projects including facility builds, FDA remediation, training and QMS implementation.
Site Director
David has 20 years’ experience across the pharmaceutical and medical device industries, with senior leadership roles spanning engineering, technical functions and operations. After graduating in Mechanical Engineering, he began his career at GlaxoSmithKline, working across API, solid-dose and aseptic manufacturing. He later held senior positions at BTG and Boston Scientific, where he led terminal sterile manufacturing operations and the transfer of pharmaceutical and medical device processes into new facilities. At Thermo Fisher Scientific, David was responsible for clinical trial and commercial packaging operations before joining Eramol as Site Director, overseeing both sterile and non-sterile manufacturing facilities.
David’s expertise includes technology transfer, process design, facility and equipment installation, qualification and validation, aseptic processing and terminal sterilisation. He also has extensive experience in operational excellence, using Lean and Six Sigma principles to improve quality, delivery, cost and productivity. As a qualified HAZOP Leader, he brings strong expertise in process safety, risk management and regulatory compliance.
Commercial Director
Nathan has over 12 years’ commercial experience across the pharmaceutical, biotechnology and diagnostics sectors. His career has focused on building trusted client relationships, understanding complex programme needs and connecting sponsors with practical solutions that support successful development and clinical supply. Before joining Eramol as Commercial Director, Nathan was part of the senior leadership team at Eurofins BioPharma, where he led the UK commercial team and delivered sustained growth across GMP testing services. Earlier in his career, he worked at Johnson & Johnson, gaining experience within a global healthcare organisation. At Eramol, Nathan leads commercial strategy across sterile and non-sterile manufacturing, packaging, testing and clinical supply.
Head of Finance
Head of HR and Governance
- Mike Hadebe
Head of Quality & Qualified Person
- Mike Hadebe
Mike has over 12 years’ experience in the pharmaceutical industry. He is a UK and EU Qualified Person with expertise spanning Quality Assurance, regulatory compliance, pharmaceutical manufacturing and the certification of investigational and commercial medicinal products. After qualifying as a pharmacist, he developed his career in the NHS across a range of roles in Technical Services, Clinical Trials and GMP QA before joining Eramol as Head of Quality, where he leads the Quality Group and supports sterile and non-sterile manufacturing operations. Mike’s expertise includes GMP compliance, aseptic manufacturing, supply chain and vendor assurance, sterile facility qualification, technology transfer, inspection readiness and quality risk management, ensuring compliance with UK and EU GMP reqs.
CEO & Co-Founder
CEO & Co-Founder
Senior Advisor to Directors
Dave has a first class honours degree in Management Banking and Finance and over 21 years banking experience. He specialises in risk management and is a specialist member of the Institute of Risk Management with strong compliance and corporate governance experience. Dave is a Chief Risk Officer and Money Laundering Reporting Officer. Dave independently challenges and supports our business operations to ensure we maintain effective systems and controls. Dave also brings a strong community focus to our business along with a focus on strategy, culture and people, ensuring we attract, retain and develop our talented people.
General Counsel
Royford is a dual qualified (UK/Hong Kong) lawyer with over 20 years of commercial and corporate legal experience. He is tri-lingual, entrepreneurial and globally experienced. He was the Corporate Counsel and head of international commercial legal team of Alibaba Group and the General Counsel of 51 Group (which is a UK and China e-commerce and logistics services provider). Royford doesn;t only have substantial legal experience, and was a member of the senior management and corporate strategy team team of his former employer.
Site Director
Commercial Director
Head of Finance
Head of HR and Governance
More About Us
Company
The company is privately owned. As a private equity-free company, Eramol is able to act in the best interests of the Company and its Clients, with a focus on service, delivery and innovation.
People
Eramol was founded on the shared values of the co-founders to offer a tailored and responsive clinical trial manufacturing services to sponsors with a wide set of requirements.
Our Approach
Eramol has developed a profound customer process that aims to deliver complete satisfaction to our clients at every stage.
Accreditations
Eramol is an authorised organisation across many strategic areas of the business. Accreditations relate to MHRA, HPRA, MHRA GDP and WDA(v). We work with all relevant bodies to ensure the very latest accreditations are in line with ongoing, continuous developments in the industry.